ESC Premium Access

Rapid platelet P2Y12 iinhibition in acute coronary syndromes

Event: ESC CONGRESS 2016
Topic: Thrombosis and platelets
Session type: Advances in Science
Date: 30 August 2016
Time: 16:30 - 18:00

Session

5 presentations in this session

State of the art in platelet P2Y12 iinhibition in acute coronary syndromes

Speaker: Professor J. Collet (Paris, FR)
Thumbnail

Greater efficacy of prasugrel and ticagrelor administered at first medical contact compared to a switching strategy during the first hours after primary percutaneous coronary intervention

Speaker: Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)
Thumbnail

Chewing versus traditional swallowing of ticagrelor to accelerate platelet inhibition in acute coronary syndrome- the CHEERS study

Speaker: Doctor E. Asher (Jerusalem, IL)
Thumbnail

Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials

Speaker: Doctor A. Eisen (Petah Tikva, IL)
Thumbnail

Future direction for research in platelet P2Y12 iinhibition in acute coronary syndromes

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

5 speakers from this session

Professor Jean-Philippe Collet

Sorbonne Universite Pitie Salpetriere Hospital, Paris (France)
17 presentations
0 follower

Doctor Ana Lucrecia Marcano Fernandez

, L'hospitalet De Llobregat (Spain)
0 follower

Doctor Elad Asher

Shaare Zedek Medical Center, Jerusalem (Israel)
0 follower

Doctor Alon Eisen

Rabin Medical Center, Beilinson Hospital, Petah Tikva (Israel)
1 presentation
0 follower

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

This platform is supported by

logo Novo Nordisk